| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |